| Product NDC: | 13537-110 |
| Proprietary Name: | CYZONE |
| Non Proprietary Name: | Octinoxate, Oxybenzone, Octisalate, and Titanium dioxide |
| Active Ingredient(s): | .075; .05; .05; .00948 g/mL; g/mL; g/mL; g/mL & nbsp; Octinoxate, Oxybenzone, Octisalate, and Titanium dioxide |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LOTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 13537-110 |
| Labeler Name: | Ventura Corporation Limited |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20110422 |
| Package NDC: | 13537-110-06 |
| Package Description: | 1 BOTTLE in 1 CARTON (13537-110-06) > 5 mL in 1 BOTTLE (13537-110-05) |
| NDC Code | 13537-110-06 |
| Proprietary Name | CYZONE |
| Package Description | 1 BOTTLE in 1 CARTON (13537-110-06) > 5 mL in 1 BOTTLE (13537-110-05) |
| Product NDC | 13537-110 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Octinoxate, Oxybenzone, Octisalate, and Titanium dioxide |
| Dosage Form Name | LOTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20110422 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Ventura Corporation Limited |
| Substance Name | OCTINOXATE; OCTISALATE; OXYBENZONE; TITANIUM DIOXIDE |
| Strength Number | .075; .05; .05; .00948 |
| Strength Unit | g/mL; g/mL; g/mL; g/mL |
| Pharmaceutical Classes |